Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nussbaum Ran
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-13
Purchase
2021-05-17
07:02 am
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
5,925,925$1.35$7,999,9997,804,778
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc.KROSNussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:16 pm
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
437,499$16$6,999,984149,262
(Indirect)
View
2019-06-27
Purchase
2019-07-01
11:50 am
ARQULE INCARQLNussbaum Ran
Director
307,692$9.75$2,999,99745,534
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:51 pm
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
200,000$9$1,800,0007,212,186
(Indirect)
View
2018-07-13
Purchase
2018-10-22
2:54 pm
ARQULE INCARQLNussbaum Ran
Director
181,818$5.5$999,9991,639,268
(Indirect)
View
2018-05-18
Purchase(A)
2018-05-22
09:22 am
ARQULE INCARQLNussbaum Ran
Director
8,611$3.29$28,3306,616,611
(Indirect)
View
2018-05-18
Purchase
2018-05-18
5:41 pm
ARQULE INCARQLNussbaum Ran
Director
8,611$3.29$28,3308,611
(Direct)
View
2018-04-30
Purchase
2018-05-01
4:34 pm
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
350,000$9.75$3,412,5007,708,582
(Indirect)
View
2018-03-21
Purchase
2018-03-23
4:20 pm
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
12,600$7.7643$97,8307,615,249
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-29
Exercise
2022-11-30
4:40 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
7,176$01,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:40 pm
N/A
N/A
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2020-04-07(A)
Ownership
2022-11-30
4:36 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
0$07,176
(Indirect)
View
2022-10-21
Exercise
2022-10-25
4:57 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
47,999$5.941,481,927
(Indirect)
View
2022-10-21
Exercise
2022-10-25
4:57 pm
2018-12-27
2022-12-27
UroGen Pharma Ltd.URGNNussbaum Ran
Director
47,999$01,481,927
(Indirect)
View
2022-06-06
Exercise
2022-08-25
3:25 pm
2015-09-01
2022-08-31
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$01,433,928
(Indirect)
View
2022-06-06
Exercise
2022-08-25
3:25 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$51,433,928
(Indirect)
View
2022-06-15
Option Award
2022-06-17
08:26 am
N/A
2032-06-15
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
20,000$020,000
(Direct)
View
2022-06-08
Option Award
2022-06-10
3:36 pm
N/A
2032-06-08
UroGen Pharma Ltd.URGNNussbaum Ran
Director
10,000$010,000
(Indirect)
View
2022-06-01
Option Award
2022-06-03
4:30 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
8,293$08,293
(Direct)
View
2021-03-25(A)
Exercise
2021-06-09
1:46 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$01,431,717
(Indirect)
View
2021-03-25(A)
Exercise
2021-06-09
1:46 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$51,431,717
(Indirect)
View
2021-03-25
Option Award
2021-06-09
1:42 pm
N/A
2031-06-06
UroGen Pharma Ltd.URGNNussbaum Ran
Director
10,000$01,443,928
(Indirect)
View
2021-03-25
Exercise
2021-06-09
1:42 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd.URGNNussbaum Ran
Director
2,211$01,443,928
(Indirect)
View
2021-03-25
Exercise
2021-06-09
1:42 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
2,211$51,443,928
(Indirect)
View
2021-06-01
Option Award
2021-06-03
5:34 pm
N/A
2031-05-31
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
8,293$08,293
(Direct)
View
2021-05-19
Option Award
2021-05-20
4:10 pm
N/A
2031-05-19
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
20,000$020,000
(Direct)
View
2021-03-24
Exercise
2021-04-22
5:18 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$01,465,199
(Indirect)
View
2021-03-24
Exercise
2021-04-22
5:18 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
1,030$51,465,199
(Indirect)
View
2021-01-22
Equity Swap
2021-01-26
5:07 pm
N/A
N/A
Prevail Therapeutics Inc.PRVLNussbaum Ran
Director
1,576,881$00
(Indirect)
View
2021-01-22
Disposition
2021-01-26
5:07 pm
N/A
N/A
Prevail Therapeutics Inc.PRVLNussbaum Ran
Director
17,000$00
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:38 pm
N/A
2030-06-17
Prevail Therapeutics Inc.PRVLNussbaum Ran
Director
17,000$017,000
(Direct)
View
2020-06-08
Option Award
2020-06-10
6:41 pm
N/A
2030-06-07
UroGen Pharma Ltd.URGNNussbaum Ran
Director
10,000$010,000
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
20,000$020,000
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
3,545,100$0149,262
(Indirect)
View
2020-04-07
Ownership
2020-04-07
7:34 pm
N/A
N/A
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
0$04,297,008
(Indirect)
View
2020-01-16
Disposition
2020-01-16
3:57 pm
N/A
2027-11-08
ARQULE INCARQLNussbaum Ran
Director
90,000$00
(Direct)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INCARQLNussbaum Ran
Director
8,744,820$200
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
2022-05-08
ARQULE INCARQLNussbaum Ran
Director
1,669,714$02,134,350
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
N/A
ARQULE INCARQLNussbaum Ran
Director
1,669,714$1.752,134,350
(Indirect)
View
2019-12-24
Tax Withholding
2019-12-27
8:48 pm
N/A
N/A
ARQULE INCARQLNussbaum Ran
Director
145,301$20.112,134,350
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
2021-10-20
ARQULE INCARQLNussbaum Ran
Director
114,286$03,438,363
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
N/A
ARQULE INCARQLNussbaum Ran
Director
114,286$1.753,438,363
(Indirect)
View
2019-06-19
Ownership
2019-06-19
6:33 pm
N/A
N/A
Prevail Therapeutics Inc.PRVLNussbaum Ran
Director
0$01,576,881
(Indirect)
View
2019-06-03
Option Award
2019-06-05
4:55 pm
N/A
2029-06-02
UroGen Pharma Ltd.URGNNussbaum Ran
Director
10,000$010,000
(Direct)
View
2019-05-29(A)
Option Award
2019-05-30
3:45 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
20,000$020,000
(Direct)
View
2019-05-29
Option Award
2019-05-29
5:21 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
20,000$020,000
(Direct)
View
2019-05-14
Option Award
2019-05-15
12:44 pm
N/A
2029-05-13
ARQULE INCARQLNussbaum Ran
Director
40,000$040,000
(Direct)
View
2019-01-01
Ownership
2019-01-10
5:16 pm
N/A
N/A
UroGen Pharma Ltd.URGNNussbaum Ran
Director
0$01,485,168
(Indirect)
View
2018-06-15
Option Award
2018-06-19
6:17 pm
N/A
2028-06-15
Eloxx Pharmaceuticals Inc.ELOXNussbaum Ran
Director
40,000$040,000
(Direct)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
2022-05-08
ARQULE INCARQLNussbaum Ran
Director
8,392,000$09,979,000
(Indirect)
View
2018-05-08
Option Award
2018-05-10
12:45 pm
N/A
2028-05-08
ARQULE INCARQLNussbaum Ran
Director
20,000$020,000
(Direct)
View
(A) Indicate amendment filing.